Lobbying client
KAILERA THERAPEUTICS INC.
Biotechnology company.
Filings
2
Filed by
1
Reported in-house
—
Reported by firms
$20,000
Filings
2 filings, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
3rd Quarter - Report 3rd Quarter 2026
|
W STRATEGIES, LLC | $20,000 reported |
|
Registration 3rd Quarter 2026
|
W STRATEGIES, LLC | — reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| W STRATEGIES, LLC | 1 | $20,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Pharmacy | PHA | 2 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.